Affiliation:
1. Central Research Institute of Epidemiology, Federal Service on Customers Rights Protection Human Well-being Surveillance
Abstract
Relevance According to many researchers, hepatitis D worsens the prognosis of hepatitis B in 80–90% of cases, accelerating fibrosis and leading to liver cirrhosis or hepatocellular carcinoma. Aims. To present a review of data on prevalence of hepatitis D in the Russian Federation and abroad. Conclusions. Hepatitis D is most common in such regions of the world as: Africa, South America, Middle East, North Asia and in some Mediterranean countries. Conclusions. Injecting drug users play a large role among vulnerable populations. Hepatitis B vaccination limits the spread of hepatitis D.
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,Epidemiology
Reference45 articles.
1. Lerut J.P., Donataccio M., Ciccarelli O., et al. Liver transplantation and HBsAg-positive postnecrotic cirrhosis: adequate immunoprophylaxis and delta virus co-infection as the significant determinants of long-term prognosis. J Hepatol. 1999. Vol. 30, № 4. P. 706–714. doi: 10.1016/s0168-8278(99)80203-7
2. Isaeva O.V., Kuregyan K.K. Viral hepatitis delta: an underestimated threat. Infektsionnye bolezni: novosti, mneniya, obuchenie. Infectious Diseases: News, Opinions, Training. 2019;8(2):72–79 (In Russ). doi: 10.24411/2305-3496-2019-12010
3. Miao Z, Zhang S, Ou X, et al. Estimating the Global Prevalence, Disease Progression, and Clinical Outcome of Hepatitis Delta Virus Infection. J Infect Dis. 2020 Apr 27;221(10):1677–1687. doi: 10.1093/infdis/jiz633.
4. Chen H.Y., Shen D.T., Ji D.Z., et al. Prevalence and burden of hepatitis D virus infection in the global population: a systematic review and meta-analysis Gut. 2019. Vol. 68, № 3. P. 512–521. doi: 10.1136/gutjnl-2018-316601
5. Vlachogiannakos J, Papatheodoridis GV. New epidemiology of hepatitis delta. Liver Int. 2020. Vol. 40, Suppl. P. 148–153. doi: 10.1111/liv.14357